Skip to Content

Argenica Therapeutics Ltd Ordinary Shares AGNTF

Morningstar Rating
Find similar stocks with Morningstar Investor.
Morningstar analysts do not currently cover AGNTF, but with our powerful screener, you can find stocks in the same sector, industry, or style and filter on our unbiased ratings and valuation metrics.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
AGNTF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AGNTF
Quick Ratio
4.23
Current Ratio
4.25
Interest Coverage
Quick Ratio
AGNTF

Profitability

Metric
AGNTF
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
AGNTF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRJftwchsfVqln$605.7 Bil
VRTX
Vertex Pharmaceuticals IncRlhwtxtlBmrxhvj$116.3 Bil
REGN
Regeneron Pharmaceuticals IncMzfkwtqQgjscfn$108.5 Bil
MRNA
Moderna IncWsxxxqtjDplx$62.9 Bil
BNTX
BioNTech SE ADRBcmrjhphXckw$23.9 Bil
ARGX
argenx SE ADRBycrsrwlKjfj$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncQzjrhjvPzttqy$18.9 Bil
BMRN
Biomarin Pharmaceutical IncDbhnmrtpLdfxxk$14.3 Bil
INCY
Incyte CorpDljxsfdTlwzyc$12.9 Bil
UTHR
United Therapeutics CorpSbwrjpfzBvcv$12.1 Bil

Sponsor Center